PHYTOTECH THERAPEUTICS
PhytoTech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an exclusive worldwide licensing agreement with Yissum Research Development Company, the commercial arm of the University of Jerusalem, for a proprietary lipid Nano technology.
PHYTOTECH THERAPEUTICS
Industry:
Biotechnology Cannabis Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Status:
Active
Similar Organizations
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Foldscope
Foldscope has developed a magnification of 140X and 2-micron resolution
Green Sky Labs
Green Sky Labs develops innovative technologies that enhance the quality of plant cultivation and cannabinoid medicines development.
Hanway Associates
Hanway Associates is a strategy and corporate advisory for the cannabis sector.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Epsilon Healthcare
Epsilon Healthcare focused on the manufacturing and distribution of hydroponics equipment, materials and nutrients.
More informations about "PhytoTech Therapeutics"
PhytoTech Therapeutics - Crunchbase Company Profile & Funding
PhytoTech Therapeutics has developed advanced oral delivery formulations for cannabinoid-based prescription drugs.See details»
Harvest One Completes Acquisition of Israeli-based Phytotech …
Nov 20, 2018 In consideration for the acquisition of PTL, Harvest One paid C$1,000,000 in cash and 8,326,694 Harvest One common shares.See details»
PhytoTech Therapeutics - PitchBook
Information on acquisition, funding, investors, and executives for PhytoTech Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Harvest One Completes Acquisition of Israeli-based …
Nov 20, 2018 Founded in 2014, Phytotech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an …See details»
Harvest One Completes Acquisition of Israeli-based Phytotech …
Nov 20, 2018 In consideration for the acquisition of PTL, Harvest One paid C$1,000,000 in cash and 8,326,694 Harvest One common shares. Founded in 2014, Phytotech has developed …See details»
PhytoTech Therapeutics acquired by Harvest One Cannabis Inc.
Jun 25, 2018 Harvest One Cannabis Inc. acquires PhytoTech Therapeutics on 2018-06-25 for an undisclosed amountSee details»
Harvest One acquires Phytotech Therapeutics from …
Nov 21, 2018 Harvest One acquires Phytotech Therapeutics from MMJ Group Holdings for $1 million, shares PTL was further responsible for administrating the successful clinical trials, both Phases 1 and 2, using Satipharm’s proprietary …See details»
Cann Group Limited completed the acquisition of Satipharm Ltd ...
Mar 9, 2021 Cann Group Limited signed a share sale agreement to acquire Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. for CAD 4 …See details»
MMJ Completes Sale of Phytotech Therapeutics Limited
Nov 21, 2018 MMJ Group Holdings Limited (ABN 91 601 236 417) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across …See details»
Harvest One Enters Pharmaceutical Market via Acquisition of …
Jun 25, 2018 Andreas Gedeon, Managing Director and CEO of Harvest One, said: “The acquisition of PhytoTech Therapeutics marks an important strategic step in the further …See details»
PhytoTech Therapeutics - CB Insights
Nov 21, 2018 About PhytoTech Therapeutics PhytoTech Therapeutics has developed advanced oral delivery systems for cannabinoid-based prescription drugs and holds an exclusive global …See details»
PhytoTech Medical Limited and Canadian MMJ
About PhytoTech Medical Limited high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis laws. With research …See details»
Harvest One Completes Sale of Satipharm for Approximately $4 …
Mar 10, 2021 Vancouver, British Columbia--(Newsfile Corp. - March 10, 2021) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF), a uniquely positioned cannabis-infused CPG …See details»
PHASE 2 CLINICAL TRIAL FOR TREATMENT OF PEDIATRIC …
MMJ’s Israel-based subsidiary, PhytoTech Therapeutics Ltd, is responsible for the Company’s R&D and clinical activities, with a key focus on the development and commercialisation of new …See details»
Harvest One Announces Agreement to Sell Satipharm for …
Feb 17, 2021 Harvest One Cannabis Inc. (“ Harvest One ” or the “ Company “) ( TSX-V: HVT; OTCQX: HRVOF ), a uniquely positioned, cannabis-infused CPG leader, announced today …See details»
Cannabidiol/tetrahydrocannabinol - PhytoTech Therapeutics
PhytoTech Therapeutics (subsidiary of MMJ PhytoTech) is developing oral PTL 201 containing 5mg delta-9- tetrahydrocannabinol- (THC) and 5mg cannabidiol (CBD),See details»
The safety, tolerability, and effectiveness of PTL-101, an oral ...
Sep 1, 2019 Editorial assistance in the preparation of this article was provided by Dr. Yehudit Posen of PSW Ltd. Support for this assistance was funded by Phytotech Therapeutics Ltd. …See details»
Cannabidiol - MMJ PhytoTech - AdisInsight - Springer
Feb 22, 2022 Cannabidiol (PTL 101), an oral formulation for the treatment of intractable epilepsy was developed by PhytoTech Therapeutics (subsidiary of MMJ PhytoTech). PTLSee details»